David M Naff
Examiner (ID: 17706)
Most Active Art Unit | 1651 |
Art Unit(s) | 1302, 1643, 1657, 1208, 1808, 1207, 1803, 1802, 1651, 2899 |
Total Applications | 2218 |
Issued Applications | 1396 |
Pending Applications | 143 |
Abandoned Applications | 679 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5119436
[patent_doc_number] => 20070141150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 10/596915
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4602
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596915 | Pharmaceutical composition | Dec 22, 2004 | Abandoned |
Array
(
[id] => 4880532
[patent_doc_number] => 20080153915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Pharmaceutical Preparation For the Oral Cavity'
[patent_app_type] => utility
[patent_app_number] => 10/597963
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4651
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153915.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597963
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597963 | Pharmaceutical Preparation For the Oral Cavity | Dec 19, 2004 | Abandoned |
Array
(
[id] => 6996253
[patent_doc_number] => 20050136031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Chemically modified small molecules'
[patent_app_type] => utility
[patent_app_number] => 11/015196
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25017
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136031.pdf
[firstpage_image] =>[orig_patent_app_number] => 11015196
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/015196 | Chemically modified small molecules | Dec 15, 2004 | Issued |
Array
(
[id] => 7250391
[patent_doc_number] => 20050142169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Palatability enhanced composition and method for animal consumption'
[patent_app_type] => utility
[patent_app_number] => 11/001425
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6770
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001425
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001425 | Palatability enhanced composition and method for animal consumption | Nov 30, 2004 | Abandoned |
Array
(
[id] => 5613521
[patent_doc_number] => 20060115449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Bioabsorbable, biobeneficial, tyrosine-based polymers for use in drug eluting stent coatings'
[patent_app_type] => utility
[patent_app_number] => 11/000572
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12006
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11000572
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/000572 | Bioabsorbable, biobeneficial, tyrosine-based polymers for use in drug eluting stent coatings | Nov 29, 2004 | Abandoned |
Array
(
[id] => 5776410
[patent_doc_number] => 20060105050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Compositions comprising fenofibrate and simvastatin'
[patent_app_type] => utility
[patent_app_number] => 10/988828
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22622
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105050.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988828
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988828 | Compositions comprising fenofibrate and simvastatin | Nov 14, 2004 | Abandoned |
Array
(
[id] => 6918829
[patent_doc_number] => 20050096390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Compositions comprising fenofibrate and pravastatin'
[patent_app_type] => utility
[patent_app_number] => 10/988818
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22682
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096390.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988818 | Compositions comprising fenofibrate and pravastatin | Nov 14, 2004 | Abandoned |
Array
(
[id] => 7142972
[patent_doc_number] => 20050118256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Extended release alpha-2 agonist pharmaceutical dosage forms'
[patent_app_type] => utility
[patent_app_number] => 10/987750
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6802
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118256.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987750
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987750 | Extended release alpha-2 agonist pharmaceutical dosage forms | Nov 11, 2004 | Abandoned |
Array
(
[id] => 6967129
[patent_doc_number] => 20050234026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Method and agent for inducing apoptosis/cell death in leukemia cells'
[patent_app_type] => utility
[patent_app_number] => 10/983978
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13267
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234026.pdf
[firstpage_image] =>[orig_patent_app_number] => 10983978
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/983978 | Method and agent for inducing apoptosis/cell death in leukemia cells | Nov 8, 2004 | Abandoned |
Array
(
[id] => 5160501
[patent_doc_number] => 20070173545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Activation of hypoxia-inducible gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/578438
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15579
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173545.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578438
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578438 | Activation of hypoxia-inducible gene expression | Nov 7, 2004 | Abandoned |
Array
(
[id] => 5865137
[patent_doc_number] => 20060099267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'High-dosage extended-release formulation of gepirone'
[patent_app_type] => utility
[patent_app_number] => 10/981663
[patent_app_country] => US
[patent_app_date] => 2004-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8299
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10981663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/981663 | High-dosage extended-release formulation of gepirone | Nov 4, 2004 | Abandoned |
10/977100 | Reconstitutable microshpere compositions useful as ultrasonic contrast agents | Oct 27, 2004 | Abandoned |
Array
(
[id] => 6958006
[patent_doc_number] => 20050214376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Hydrogel-containing medical articles and methods of using and making the same'
[patent_app_type] => utility
[patent_app_number] => 10/970349
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 42716
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214376.pdf
[firstpage_image] =>[orig_patent_app_number] => 10970349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/970349 | Hydrogel-containing medical articles and methods of using and making the same | Oct 20, 2004 | Abandoned |
Array
(
[id] => 7200440
[patent_doc_number] => 20050042278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'New formulation for retinoid-containing soft gelatin capsules'
[patent_app_type] => utility
[patent_app_number] => 10/958704
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2678
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042278.pdf
[firstpage_image] =>[orig_patent_app_number] => 10958704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/958704 | New formulation for retinoid-containing soft gelatin capsules | Oct 4, 2004 | Abandoned |
Array
(
[id] => 7231054
[patent_doc_number] => 20050079214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Oral delivery system and method for making same'
[patent_app_type] => utility
[patent_app_number] => 10/956301
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11518
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079214.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956301 | Oral delivery system and method for making same | Sep 30, 2004 | Abandoned |
Array
(
[id] => 5721406
[patent_doc_number] => 20060074182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Hydrogel composition and methods for making the same'
[patent_app_type] => utility
[patent_app_number] => 10/955463
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6175
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10955463
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/955463 | Hydrogel composition and methods for making the same | Sep 29, 2004 | Abandoned |
Array
(
[id] => 178035
[patent_doc_number] => 07655744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Branched polyglycerol-modified silicone'
[patent_app_type] => utility
[patent_app_number] => 10/949390
[patent_app_country] => US
[patent_app_date] => 2004-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17019
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10949390
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/949390 | Branched polyglycerol-modified silicone | Sep 26, 2004 | Issued |
Array
(
[id] => 7050386
[patent_doc_number] => 20050186273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Controlled release dosage form including a banded engine'
[patent_app_type] => utility
[patent_app_number] => 10/950039
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11180
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10950039
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/950039 | Controlled release dosage form including a banded engine | Sep 23, 2004 | Abandoned |
Array
(
[id] => 5079147
[patent_doc_number] => 20070122371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Cleansing composition'
[patent_app_type] => utility
[patent_app_number] => 10/574494
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12992
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122371.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574494
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574494 | Cleansing composition | Sep 23, 2004 | Issued |
Array
(
[id] => 6996224
[patent_doc_number] => 20050136002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters'
[patent_app_type] => utility
[patent_app_number] => 10/945852
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19110
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945852 | Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters | Sep 20, 2004 | Abandoned |